BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 6388965)

  • 21. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
    Bruneau C; Bonin H
    Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absorbance nephelometry of immune complexes by reaction with anti-IgG after treatment with polyethylene glycol.
    Levinson SS; Goldman J
    Clin Chem; 1983 Dec; 29(12):2035-9. PubMed ID: 6605818
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
    Ferraccioli G; Karsh J; Osterland CK
    J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
    Valentijn RM; van Es LA; Daha MR
    J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune complexes in diabetes mellitus: studies of complement utilisation and tissue deposition.
    Charlesworth JA; Campbell LV; Catanzaro R; Pussell BA; Pasterfield GV; Peake P
    J Clin Lab Immunol; 1982 Sep; 8(3):163-8. PubMed ID: 6752415
    [No Abstract]   [Full Text] [Related]  

  • 26. Beta2-microglobulin-containing IgG complexes in sera and synovial fluids of rheumatoid arthritis and systemic lupus erythematosus patients.
    Falus A; Merétey K; Glikmann G; Svehag SE; Fábián F; Böhm U; Bozsöky S
    Scand J Immunol; 1981; 13(1):25-34. PubMed ID: 6165072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of high salt concentration on detection of serum immune complexes and autoantibodies to C1q in patients with systemic lupus erythematosus.
    Kohro-Kawata J; Wener MH; Mannik M
    J Rheumatol; 2002 Jan; 29(1):84-9. PubMed ID: 11824976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The detection of immune complexes of different immunoglobulin class.
    Quin JW; Charlesworth JA; Macdonald GJ
    Aust N Z J Med; 1979 Dec; 9(6):644-9. PubMed ID: 294921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Circulating immune complexes-like material and complement in rheumatoid arthritis and ankylosing spondylitis (author's transl)].
    Rodrigo MJ; Gallart MT; Lience E; Arnal C; Sans J
    Med Clin (Barc); 1981 Apr; 76(8):339-46. PubMed ID: 6789016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IgG detected in the C1q solid-phase immune-complex assay is not always of immune-complex nature.
    Hack CE; Belmer AJ
    Clin Immunol Immunopathol; 1986 Jan; 38(1):120-8. PubMed ID: 3484437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune complexes in solid tumours precipitable by 3.5% polyethylene glycol: analysis of some nonspecific components.
    Guidi L; Baroni R; Bartoloni C; Pellegrino M; Tricerri A; Marciano M; Barone C; Gambassi G
    Diagn Clin Immunol; 1988; 5(6):284-8. PubMed ID: 3219777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in immunochemical characteristics of cryoglobulins in rheumatoid arthritis and systemic lupus erythematosus and their complement binding properties.
    Erhardt CC; Mumford P; Maini RN
    Ann Rheum Dis; 1984 Jun; 43(3):451-6. PubMed ID: 6611139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
    Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
    J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of the soluble immune complexes that are detected by three different techniques.
    van der Giessen M; The TH
    Clin Immunol Immunopathol; 1986 Feb; 38(2):244-55. PubMed ID: 3484441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer.
    Medof ME
    J Lab Clin Med; 1982 May; 99(5):678-92. PubMed ID: 6978370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced complement-mediated immune complex solubilizing capacity and the presence of incompletely solubilized immune complexes in SLE sera.
    Baatrup G; Petersen I; Jensenius JC; Svehag SE
    Clin Exp Immunol; 1983 Nov; 54(2):439-47. PubMed ID: 6652967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential characteristics of immune-bound antibodies in diffuse proliferative and membranous forms of lupus glomerulonephritis.
    Roberts JL; Wyatt RJ; Schwartz MM; Lewis EJ
    Clin Immunol Immunopathol; 1983 Nov; 29(2):223-41. PubMed ID: 6605223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of anti-C1q capture assay for detecting circulating immune complexes and comparison with polyethylene glycol-immunoglobulin G, C1q-binding, and Raji cell methods.
    Levinson SS; Goldman JO
    J Clin Microbiol; 1987 Aug; 25(8):1567-9. PubMed ID: 2957387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some studies on the polyethylene glycol turbidity method for detecting immune complexes in serum.
    Kilpatrick DC; Weston J; Irvine WJ
    Ann Clin Biochem; 1981 Nov; 18(Pt 6):373-7. PubMed ID: 6976150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.